The AABB is a Maryland-based association of transfusion medicine/cellular therapy professionals and institutions with 10,000 members in 80 countries. (AABB is the former “American Association of Blood Banking,” whose members “collect most of the US blood supply,” according to a Wall Street Journal report.)
On June 18, a task force convened by AABB to assess the risk of transmitting XMRV via transfusion of ME/CFS patients’ blood advised the organization’s member blood collectors to “actively discourage” individuals ever diagnosed with ME/CFS from donating blood or blood components.
Task force members included representatives of the CDC, FDA, NIH, Office of the Assistant Secretary for Health, XMRV researchers, the blood community & patient advocates.
They note that this is an interim measure until further definitive data are available, and that at this time there are no federal donor eligibility regulations pertaining to XMRV in the US.
To read the AABB announcement, click here.